Trial Profile
A phase II study to evaluate the effect of induction therapy using idarubicin and infusional high-dose cytarabine on mortality rate and haematological toxicity in adult patients with de novo untreated acute lymphoblastic leukaemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Jun 2016
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Idarubicin (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 18 Jul 2011 New trial record